Case Study: Mr. John, a 55-year-old diabetic, has battled with hypertension for over a decade. Two years ago, he received the devastating diagnosis of chronic kidney disease (CKD) stage 3b. Despite diligent adherence to his medication regimen, his kidney function progressively declined, and proteinuria, a marker of damage, remained stubbornly elevated. The future looked bleak, … Continue reading Unveiling Relaxin’s Potential in CKD